Video Series

An expert highlights unmet needs in the treatment of Rett syndrome.

Nonmedication COPD strategies, such as pulmonary rehabilitation, are highlighted.

Selecting appropriate inhalers based on individual characteristics and shared decision-making is crucial for optimizing care for patients with COPD.

Daratumumab can be an effective frontline MM treatment option.

Raymond Thertulien, MD, PhD, discusses high-risk factors for patients with MM.

Key opinion leaders discuss the role of combination therapies in the management of diabetes.

Managing hypertension is a critical aspect of diabetes disease management.

Considerations for insurance preauthorization and reauthorization are explored by a key opinion leader.

Patients and families facing a Rett syndrome diagnosis experience an array of burdens.

Early effective treatment strategies can have a significant impact on long-term effects for patients with MDD.

The panel shares insights into the evolution of treatment strategies for patients with diabetes.

A panel of experts discuss considerations in insurance coverage for the treatment of patients with diabetes.

Brea C. Lipe, MD, highlights considerations for frail patients when treating for MM.

Medical experts explore the SWOG-S0777 trial and present an overview of daratumumab in combination with lenalidomide and dexamethasone (DRd) vs bortezomib, lenalidomide, and low-dose dexamethasone (VRd).

Inhaler technique informs health care outcomes in COPD management and should be a primary focus in patient education priorities.

Treatment pathways, including escalation and de-escalation of therapy, for patients with COPD are explored by a panel of medical experts.

Patient advocate Paige Nues elaborates on the patient journey associated with a Rett syndrome diagnosis.

Paige Nues, from the International Rett Syndrome Foundation, provides insights on the diagnostic journey for patients with Rett syndrome.

Drs Weaver and Chitre discuss aligning key considerations for payers and goals of therapy for patients in the treatment of MDD.

Drs Weaver and Chitre share strategies to support MDD treatment adherence across their patient populations.

Bruce Sherman, MD, FCCP, FACOEM, underlines the impact of health inequities for patients diagnosed with psoriasis.

Maria Lopes, MD, MS, provides an overview of the PASI scoring system.

Amy McMichael, MD, discusses the impact of psoriasis on a patient’s quality of life.

Ryan Haumschild, PharmD, MS, MBA, leads a panel discussion highlighting the current prevalence of psoriasis.

Dr Brinton provides insights regarding prognosis for patients with HoFH.

Eliot Brinton, MD, opens a discussion surrounding the treatment landscape for patients with homozygous familial hypercholesterolemia (HoFH).

David Lieberman, MD, PhD, reviews the potential role and the goals of gene therapy in the treatment of Rett syndrome.

In their closing thoughts, experts emphasize their optimism regarding the direction of LN treatment strategies and resources.